BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19020245)

  • 21. Multiple endocrine neoplasia type 1 in end-stage renal failure.
    Suzuki H; Katoh T; Sakuma Y; Takahashi M; Asahi K; Hashimoto S; Kosugi S; Suzuki S; Takenoshita S; Watanabe T
    Clin Exp Nephrol; 2004 Dec; 8(4):380-3. PubMed ID: 15619041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1).
    Turner JJ; Christie PT; Pearce SH; Turnpenny PD; Thakker RV
    Hum Mutat; 2010 Jan; 31(1):E1089-101. PubMed ID: 19953642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy.
    Chen HH; Lin CJ; Wu CJ; Lai CT; Lin J; Cheng SP; Yang TL
    Ann Surg; 2011 Apr; 253(4):786-90. PubMed ID: 21475021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy.
    Coutinho FL; Lourenço DM; Toledo RA; Montenegro FL; Correia-Deur JE; Toledo SP
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):462-8. PubMed ID: 19650788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microwave ablation for recurrent primary hyperparathyroidism in four patients with multiple endocrine neoplasia type 1: a case series report.
    Tan J; Zhang Y; Han X; Fan Y; Xu J; Chen G; Liu C; Xu S
    Int J Hyperthermia; 2024; 41(1):2308056. PubMed ID: 38314667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel 14 base-pair deletion of the MEN1 gene in a patient with recurrent primary hyperparathyroidism.
    Katai M; Sakurai A; Uchino S; Minemura K; Hashizume K; Fukushima Y
    Jpn J Clin Oncol; 2006 Jun; 36(6):395-7. PubMed ID: 16714299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Percutaneous ethanol injection of parathyroid adenoma under US guidance].
    Iwasaki T; Hayashi N; Kimura I; Sutoh Y; Nakashima T; Odori T; Ishii Y; Tsubokawa T
    Rinsho Hoshasen; 1989 Feb; 34(2):261-4. PubMed ID: 2666689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation.
    Shih RY; Fackler S; Maturo S; True MW; Brennan J; Wells D
    Endocr Pract; 2009; 15(6):567-72. PubMed ID: 19491073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surgical treatment of hyperparathyroidism].
    Târcoveanu E; Niculescu D; Moldovanu R; Cotea E; Vasilescu A; Dănilă N; Lăzescu D; Ferariu D; Crumpei F; Ichim M; Zbranca E
    Chirurgia (Bucur); 2009; 104(5):531-44. PubMed ID: 19943551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: experience by a single surgical team in Japan.
    Obara T; Fujimoto Y; Ito Y
    Henry Ford Hosp Med J; 1992; 40(3-4):191-4. PubMed ID: 1362403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute renal failure as an initial manifestation of multiple endocrine neoplasia (MEN) type 1.
    Afshar R; Sanavi S; Taheri HR
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):117-21. PubMed ID: 22237232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism.
    Sato K; Yamazaki K; Zhu H; Kanbe M; Iihara M; Wada Y; Tanaka R; Okamoto T; Ito Y; Obara T
    Surgery; 2000 Mar; 127(3):337-41. PubMed ID: 10715991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unusual functioning endocrine tumors.
    Raut CP; Lee JE
    Curr Treat Options Oncol; 2004 Aug; 5(4):327-34. PubMed ID: 15233909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alcoholization: an option for the treatment of hyperparathyroidism].
    Riancho JA; Lastra P; Amado JA
    Med Clin (Barc); 2009 May; 132(17):682-3. PubMed ID: 19268321
    [No Abstract]   [Full Text] [Related]  

  • 35. Modified percutaneous ethanol injection of parathyroid adenoma in primary hyperparathyroidism.
    Cappelli C; Pelizzari G; Pirola I; Gandossi E; De Martino E; Delbarba A; Agosti B; Agabiti Rosei E; Castellano M
    QJM; 2008 Aug; 101(8):657-62. PubMed ID: 18499732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid cancer: biology and management.
    Koea JB; Shaw JH
    Surg Oncol; 1999 Nov; 8(3):155-65. PubMed ID: 11113666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple endocrine neoplasia type 1 revealed by a hip pathologic fracture.
    Slouma M; Abbes M; Dhahri R; Litaiem N; Gueddiche N; Mansouri N; Msekni I; Gharsallah I; Metoui L; Louzir B
    Clin Rheumatol; 2021 Feb; 40(2):775-782. PubMed ID: 32666178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasonically guided percutaneous inactivation of parathyroid tumours.
    Karstrup S; Holm HH; Torp-Pedersen S; Hegedüs L
    Br J Radiol; 1987 Jul; 60(715):667-70. PubMed ID: 3304509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invited Commentary: Less than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.
    Palazzo FF
    World J Surg; 2022 Nov; 46(11):2676-2677. PubMed ID: 36042033
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiple endocrine neoplasia type I.
    Zarnegar R; Brunaud L; Clark OH
    Curr Treat Options Oncol; 2002 Aug; 3(4):335-48. PubMed ID: 12074770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.